newsfilter
← Latest News
GlobeNewswire·

Pluri Chairman and Active Investor Alejandro Weinstein to Acquire EIB Loan, in Strong Vote of Confidence in the Company

PLUR
  • Pluri Inc. announced that Alejandro Weinstein, its Chairman & largest shareholder, agreed to acquire the Company's loan from the European Investment Bank (EIB).
  • Upon completion, Weinstein will replace the EIB as lender & succeed to all associated rights & remedies while the underlying loan remains outstanding.
  • The transaction transfers a significant financing obligation from the EIB to Weinstein, establishing a more direct & flexible framework for debt resolution.
  • Pluri & Weinstein intend to negotiate revised loan terms soon to present a long-term resolution plan, allowing management to focus on commercialization.
  • Weinstein stated the move expresses his confidence in Pluri's technology & strategy, aiming to accelerate its evolution in regenerative medicine & longevity.
  • CEO Yaky Yanay confirmed the lender change creates a more aligned framework at a critical time for the Company's commercial execution.
  • The assignment was reviewed & approved by a special independent committee of the Board & by the Board with majority independent director support.
  • Weinstein has a track record of over 20 M&A transactions & exits exceeding $5 billion, including the sale of CFR Pharmaceuticals to Abbott.
  • Pluri develops cell-based solutions using its proprietary 3D cell expansion platform for health, longevity, & CDMO services.
  • The press release includes standard forward-looking statements & risk factors regarding potential delays in negotiations or changes in market conditions.